We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Arbor Pharma to Acquire XenoPort

News   May 24, 2016

 
Arbor Pharma to Acquire XenoPort
 
 
 

RELATED ARTICLES

Broccoli Compound Restores Potent Cancer Cell Suppressor Function

News

Researchers report that indole-3-carbinol (I3C) – a natural compound found in broccoli – can be used to therapeutically target a gene (WWP1) known to play a role in several human cancers.

READ MORE

Progress in Priming Stem Cell Cardiomyocyte Maturation

News

Speeding up the transformation of induced pluripotent stem cells into cardiomyocytes is of interest for researchers involved in regenerative medicine, and drug development for cardiac diseases.

READ MORE

Chip Platform a Tool for Modeling Drug Effects on Unborn Children

News

ETH researchers have combined embryonic cells and liver cells in a new cell culture test. This combination lets them detect adverse effects that new medications may have on embryos early on in the drug development process.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE